Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2017

Industry: 

656 Views
Buy This Report

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Metachromatic Leukodystrophy (MLD) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

  • 656 reads